Coronavirus

Leaving middle seats open and vacant on airplanes may significantly reduce a passenger’s risk of exposure to the coronavirus, a new study published by the U.S. Centers for Disease Control and Prevention suggests.

The CEO of pharmaceutical giant Pfizer said during a televised interview Thursday that people will "likely" need a third dose of the COVID-19 vaccine.

FEMA said it was inundated with over 1 million calls from people requesting assistance with COVID-19-related funeral expenses on its first day of application processing.

Dr. Anthony Fauci, the nation’s leading expert on infectious diseases, said the longer the novel coronavirus is allowed to replicate in any part of the world, the more opportunity new variants have to emerge and threaten the country’s chance of reaching herd immunity.

Here are some answers to common questions about COVID-19 vaccine cards, including what happens if it is lost or damaged.

Nearly half of American adults have gotten at least one dose of the vaccine, and about 30% have been fully vaccinated. But the picture is still relentlessly grim in parts of Europe, Latin America, Africa and Asia.

The number of Americans applying for unemployment benefits fell sharply last week to 576,000, a hopeful sign that layoffs are easing as the economy recovers from the pandemic recession.

New research has found that most kids with a serious inflammatory illness linked to the coronavirus had no COVID-19 symptoms or just mild ones. Another small study found that many MIS-C patients also suffered neurological symptoms.

The spring season correlates with increased pollen counts, and according to a new study, the common allergen could be making COVID-19 infection rates worse.

A potential HIV vaccine that utilizes he same mRNA technology as the COVID-19 vaccine from Moderna is showing promising results.

The pause on Johnson & Johnson’s COVID-19 vaccine will remain in place for now after U.S. health advisers said they need more evidence to make any decision about the rare blood clots reported.

The NFL announced Wednesday that more than 2 million COVID-19 vaccinations have been administered at its stadiums and facilities since starting the campaign earlier this year.

Johnson & Johnson said it will pause an ongoing trial of its COVID-19 vaccine after federal health officials recommended the action in the wake of six reported U.S. cases of a rare type of blood clotting following vaccination.

Moderna said its latest Phase 3 clinical trial found that its vaccine remains greater than 90% effective against COVID-19, and greater than 95% effective against severe cases of COVID-19, six months after the second dose.